Zyversa Therapeutics Stock Forecast

Sell candidate since Jun 22, 2026 Gain 2.13%

The ZyVersa Therapeutics, Inc. stock price gained 2.13% on the last trading day (Tuesday, 23rd Jun 2026), rising from $0.165 to $0.169. During the last trading day the stock fluctuated 15.69% from a day low at $0.161 to a day high of $0.186. The price has risen in 4 of the last 10 days but is still down by -3.65% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 127 more shares were traded than the day before. In total, 177 shares were bought and sold for approximately $29.83 .

The stock lies in the lower of a wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.163 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -14.55% during the next 3 months and, with a 90% probability hold a price between $0.139 and $0.173 at the end of this 3-month period.

ZVSA Signals & Forecast

There are mixed signals in the stock today. The ZyVersa Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.178 and $0.187. A break-up above any of these levels will issue buy signals. A buy signal was issued from a pivot bottom point on Tuesday, June 16, 2026, and so far it has risen 2.13%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). ZyVersa Therapeutics, Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for ZyVersa Therapeutics, Inc. stock

ZyVersa Therapeutics, Inc. finds support from accumulated volume at $0.165 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0253 between high and low, or 15.69%. For the last week, the stock has had daily average volatility of 15.26%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ZVSA) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect ZyVersa Therapeutics, Inc. to open at $0.172, and during the day (based on 14 day Average True Range), to move between $0.156 and $0.181, which gives a possible trading interval of +/-$0.0256 (+/-16.44%) up or down from last closing price. If ZyVersa Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 16.44% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.165 (2.08%) than the resistance at $0.190 (12.75%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is ZyVersa Therapeutics, Inc. stock A Buy?

ZyVersa Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -3.258 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 24, 2026 - $0.172 ( 2.07%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk